STELLAR: Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05991492
Collaborator
(none)
60
2
10

Study Details

Study Description

Brief Summary

Insomnia is an important public health problem and the most common sleep disorder in the general population. Up to 20% of adults in the United States suffer from insomnia disorder, and it has been associated with increased morbidity, mortality, and healthcare costs. Cognitive behavioral therapy for insomnia (CBT-I) is the initial recommended treatment approach for insomnia. Combined therapy with CBT-I and medication has shown no advantage over CBT-I alone. CBT-I is not always accessible to patients, however, due to cost and availability of trained healthcare professionals. Web-based CBT-I is an inexpensive and effective self-management tool for treatment of insomnia.

This pilot study would test the efficacy of a new digital CBT-I application called Stellar Sleep, a cost effective and user-friendly version of wCBT-I, in patients with insomnia. This is the first digital CBT-I app that allows automatic entry of sleep diary data from wearable devices that track sleep (such as the Mi Band 5 or a FitBit, for instance). Testing the efficacy of this application will provide the preliminary data necessary for larger trials to further validate the application and determine its role for future patients. Use of this application can help bridge the gap in providing care to insomnia patients with transportation and cost barriers and to accommodate the long wait times for traditional in-person CBT-I. It will also be the first web-based CBT-I application that can directly upload data from a wearable device.

Condition or Disease Intervention/Treatment Phase
  • Device: Web-based Cognitive Behavioral Therapy for Insomnia (wCBT-I
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Web-based Cognitive Behavioral Therapy for Insomnia (wCBT-I) with general sleep education

Device: Web-based Cognitive Behavioral Therapy for Insomnia (wCBT-I
Digital insomnia treatment

No Intervention: General Sleep Education

Outcome Measures

Primary Outcome Measures

  1. Insomnia Severity Index (ISI) [6-8 weeks]

    Mean change in Insomnia Severity Index (ISI) score from baseline to end of intervention. Score ranges from 0 to 28, with higher scores indicating a worse outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years or older

  • Daily access to a computer or smartphone with reliable internet connection

Exclusion Criteria:
  • Currently pregnant or planning to become pregnant in the next year

  • Visual impairment that prevents use of a computer

  • Serious health conditions that will prevent taking part in the study over the next 3 - 6 months, such as severe medical or psychiatric disease, such as treatments for cancer or congestive heart failure, OR a condition that may require hospitalization or surgery

  • Self-reported history of drowsy driving or fallen asleep while driving

  • Night shift worker

  • Prior exposure to Cognitive Behavioral Therapy for Insomnia (CBT-I) treatment

  • Insomnia severity index score < 14

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Brigham and Women's Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sogol Javaheri, Principal Investigator, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT05991492
Other Study ID Numbers:
  • 2023P001950
First Posted:
Aug 14, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023